Groupe Berkem, a specialist in plant-based chemistry, has postponed its financial targets by one year in view of an economic context deemed to be 'adverse', sending its share price tumbling.

At the time of its IPO in 2021, the company had set itself the target of sales of at least 65 million euros by 2024, which could be increased to 85 million euros in the event of external growth operations.

For the same period, the group had expressed the ambition of achieving an operating margin (Ebitda) of around 25%.

While these objectives remain unchanged, Berkem now expects to achieve them by 2025.

Due to a deteriorating economic and geopolitical context since the conflict in Ukraine, the Group explains that it is suffering from a general rise in operating costs due to inflation.

It also says it is suffering from the sharp slowdown in the construction market, again linked to inflationary pressures.

Shortly before 10:00 a.m., its share price fell by more than 3% in a slightly lower Paris market.

Copyright (c) 2023 CercleFinance.com. All rights reserved.